作者
Michael E Farkouh, Michael Domanski, George D Dangas, Lucas C Godoy, Michael J Mack, Flora S Siami, Taye H Hamza, Binita Shah, Giulio G Stefanini, Mandeep S Sidhu, Jean-Francois Tanguay, Krishnan Ramanathan, Samin K Sharma, John French, Whady Hueb, David J Cohen, Valentin Fuster
发表日期
2019/2/19
期刊
Journal of the American College of Cardiology
卷号
73
期号
6
页码范围
629-638
出版商
American College of Cardiology Foundation
简介
Background
The FREEDOM (Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease) trial demonstrated that for patients with diabetes mellitus (DM) and multivessel coronary disease (MVD), coronary artery bypass grafting (CABG) is superior to percutaneous coronary intervention with drug-eluting stents (PCI-DES) in reducing the rate of major adverse cardiovascular and cerebrovascular events after a median follow-up of 3.8 years. It is not known, however, whether CABG confers a survival benefit after an extended follow-up period.
Objectives
The purpose of this study was to evaluate the long-term survival of DM patients with MVD undergoing coronary revascularization in the FREEDOM trial.
Methods
The FREEDOM trial randomized 1,900 patients with DM and MVD to undergo either PCI with sirolimus-eluting or paclitaxel-eluting stents or CABG on a …
学术搜索中的文章
ME Farkouh, M Domanski, GD Dangas, LC Godoy… - Journal of the American College of Cardiology, 2019